Forensics

Drug addiction has reached epidemic levels across the globe with approximately 250 million drug users worldwide and narcotic traffic keeps increasing. Law enforcement agencies have to search for new and reliable tools of counteraction against narcotics distribution. Every year a new type of drug is developed: the range of wide-spread narcotics like methamphetamines, heroin and cocaine, has been supplemented with new MDMA (ecstasy) and designer drugs (synthetic cathinones).

 

 

Instant in-field analysis

 

Enhanced Spectrometry solutions are designed to meet the needs of law enforcement agencies and contribute to control of narcotics distribution. RaPort, a portable Raman handheld spectrometer, enables quick and precise identification of all major groups of drugs (except herbals) securing instant result and immediate reaction. The embedded spectral library of RaPort contains dozens of narcotics including methamphetamines, synthetic cathinones, other narcotics and their precursors.

 

Within a few seconds RaPort  scans narcotic substances in form of liquids, powders, gels, tablets and capsules and instantly identifies their content without destroying the package and avoiding direct contact. Due to RaPort superb sensitivity the laser power of 12 mW is perfectly sufficient to rapidly acquire a high quality spectrum from a single piece of substance. Up to 6 hours of autonomous operation make the instrument highly recommended for  in-field analysis.

 

 

Hidden narcotics: Analysis of residues

 

EnSpectr software supports the unique function of the Search match mode: continuously measuring substance,  a specific drug. RaPort identifies pieces of substance at a concentration as low as 1%. Raman Microscope RamMics enables even more accurate identification of component concentration, and below 1%, with MixSplitter technology. The MixSplitter complex analyzes each mixture grain and numerically characterizes each mixture component.

Meeting GMP EU requirements. According to the GMP standards, it is necessary for pharmaceutical companies to use “effective monitoring and control systems for process performance and product quality” and ensure that “medicinal products are stored, distributed and subsequently handled so that quality is maintained throughout their shelf life” which implies:


  • New deliveries quality checks,
  • Stated substances quality confirmation,
  • Component control checks before mixing with new deliveries, etc.


The EnSpectr top product for pharmaceutical field, handheld Raman spectrometer RaPort, proves to be an efficient easy-to-use solution for pharmaceutical field providing quick measurements and accurate substance identification in less than 3 seconds.

Relevant products

L405

L405

EnSpectr L405® sets new records at blue-violet wavelengths. It is a unique luminescent analyzer that combines highest resolution and superior sensitiv...
Read More
R532

R532

EnSpectr R532® is a unique instrument that combines the advantage of a portable probe system with the performance of a highly specified laboratory ins...
Read More
Raman Microscope M785

Raman Microscope M785

Raman Microscope RamMics M785 is an optical spectral instrument with specialized software for getting enlarged images of small details of sample struc...
Read More
RaPort 1064

RaPort 1064

The only model which can identify the most challenging drugs like MDMA pills, YaBa pills, brown heroin, etc.
Read More
RaPort

RaPort

Enable identification of various chemical compounds in extremely low quantities (up to several molecules)
Read More
Raman Microscope M532

Raman Microscope M532

Raman Microscope RamMics M532® integrates the capabities of EnSpectr R532® Raman Analyzer Scientific Edition and Olympus BX-43/BX51 microscope adapte...
Read More
MixSplitter

MixSplitter

MixSplitter automatically scans powder mixtures and identifies their composition ensuring up to 0.1% contaminant identification
Read More

You can order the required device or learn more by sending us a request:

Your Name *
Email *
Message (optional)

I’ve read and agree with: Privacy Policy